Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LI3J
|
|||
Former ID |
DNC012203
|
|||
Drug Name |
2-BFi
|
|||
Synonyms |
2-Benzofuran-2-yl-4,5-dihydro-1H-imidazole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H10N2O
|
|||
Canonical SMILES |
C1CN=C(N1)C2=CC3=CC=CC=C3O2
|
|||
InChI |
1S/C11H10N2O/c1-2-4-9-8(3-1)7-10(14-9)11-12-5-6-13-11/h1-4,7H,5-6H2,(H,12,13)
|
|||
InChIKey |
YTJOHEUHUVBKSB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 72583-92-7
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:103964
|
References | Top | |||
---|---|---|---|---|
REF 1 | Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett. 2000 Mar 20;10(6):605-7. | |||
REF 2 | Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):546-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.